3D and 4D bioprinting of the myocardium: Current approaches, challenges, and future prospects

Chin Siang Ong, Lucy Nam, Kingsfield Ong, Aravind Krishnan, Chen Yu Huang, Takuma Fukunishi, Narutoshi Hibino

Research output: Contribution to journalReview article

Abstract

3D and 4D bioprinting of the heart are exciting notions in the modern era. However, myocardial bioprinting has proven to be challenging. This review outlines the methods, materials, cell types, issues, challenges, and future prospects in myocardial bioprinting. Advances in 3D bioprinting technology have significantly improved the manufacturing process. While scaffolds have traditionally been utilized, 3D bioprinters, which do not require scaffolds, are increasingly being employed. Improved understanding of the cardiac cellular composition and multiple strategies to tackle the issues of vascularization and viability had led to progress in this field. In vivo studies utilizing small animal models have been promising. 4D bioprinting is a new concept that has potential to advance the field of 3D bioprinting further by incorporating the fourth dimension of time. Clinical translation will require multidisciplinary collaboration to tackle the pertinent issues facing this field.

LanguageEnglish (US)
Article number6497242
JournalBioMed Research International
Volume2018
DOIs
StatePublished - Apr 22 2018

Fingerprint

3D printers
Tissue Scaffolds
Scaffolds
Animals
Chemical analysis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

3D and 4D bioprinting of the myocardium : Current approaches, challenges, and future prospects. / Ong, Chin Siang; Nam, Lucy; Ong, Kingsfield; Krishnan, Aravind; Huang, Chen Yu; Fukunishi, Takuma; Hibino, Narutoshi.

In: BioMed Research International, Vol. 2018, 6497242, 22.04.2018.

Research output: Contribution to journalReview article

Ong, Chin Siang ; Nam, Lucy ; Ong, Kingsfield ; Krishnan, Aravind ; Huang, Chen Yu ; Fukunishi, Takuma ; Hibino, Narutoshi. / 3D and 4D bioprinting of the myocardium : Current approaches, challenges, and future prospects. In: BioMed Research International. 2018 ; Vol. 2018.
@article{9fa65d1070f34dc78715278f93757ead,
title = "3D and 4D bioprinting of the myocardium: Current approaches, challenges, and future prospects",
abstract = "3D and 4D bioprinting of the heart are exciting notions in the modern era. However, myocardial bioprinting has proven to be challenging. This review outlines the methods, materials, cell types, issues, challenges, and future prospects in myocardial bioprinting. Advances in 3D bioprinting technology have significantly improved the manufacturing process. While scaffolds have traditionally been utilized, 3D bioprinters, which do not require scaffolds, are increasingly being employed. Improved understanding of the cardiac cellular composition and multiple strategies to tackle the issues of vascularization and viability had led to progress in this field. In vivo studies utilizing small animal models have been promising. 4D bioprinting is a new concept that has potential to advance the field of 3D bioprinting further by incorporating the fourth dimension of time. Clinical translation will require multidisciplinary collaboration to tackle the pertinent issues facing this field.",
author = "Ong, {Chin Siang} and Lucy Nam and Kingsfield Ong and Aravind Krishnan and Huang, {Chen Yu} and Takuma Fukunishi and Narutoshi Hibino",
year = "2018",
month = "4",
day = "22",
doi = "10.1155/2018/6497242",
language = "English (US)",
volume = "2018",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - 3D and 4D bioprinting of the myocardium

T2 - BioMed Research International

AU - Ong, Chin Siang

AU - Nam, Lucy

AU - Ong, Kingsfield

AU - Krishnan, Aravind

AU - Huang, Chen Yu

AU - Fukunishi, Takuma

AU - Hibino, Narutoshi

PY - 2018/4/22

Y1 - 2018/4/22

N2 - 3D and 4D bioprinting of the heart are exciting notions in the modern era. However, myocardial bioprinting has proven to be challenging. This review outlines the methods, materials, cell types, issues, challenges, and future prospects in myocardial bioprinting. Advances in 3D bioprinting technology have significantly improved the manufacturing process. While scaffolds have traditionally been utilized, 3D bioprinters, which do not require scaffolds, are increasingly being employed. Improved understanding of the cardiac cellular composition and multiple strategies to tackle the issues of vascularization and viability had led to progress in this field. In vivo studies utilizing small animal models have been promising. 4D bioprinting is a new concept that has potential to advance the field of 3D bioprinting further by incorporating the fourth dimension of time. Clinical translation will require multidisciplinary collaboration to tackle the pertinent issues facing this field.

AB - 3D and 4D bioprinting of the heart are exciting notions in the modern era. However, myocardial bioprinting has proven to be challenging. This review outlines the methods, materials, cell types, issues, challenges, and future prospects in myocardial bioprinting. Advances in 3D bioprinting technology have significantly improved the manufacturing process. While scaffolds have traditionally been utilized, 3D bioprinters, which do not require scaffolds, are increasingly being employed. Improved understanding of the cardiac cellular composition and multiple strategies to tackle the issues of vascularization and viability had led to progress in this field. In vivo studies utilizing small animal models have been promising. 4D bioprinting is a new concept that has potential to advance the field of 3D bioprinting further by incorporating the fourth dimension of time. Clinical translation will require multidisciplinary collaboration to tackle the pertinent issues facing this field.

UR - http://www.scopus.com/inward/record.url?scp=85046703167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046703167&partnerID=8YFLogxK

U2 - 10.1155/2018/6497242

DO - 10.1155/2018/6497242

M3 - Review article

VL - 2018

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 6497242

ER -